Cardiac biomarkers play a pivotal role in modern healthcare, providing valuable insights into the functioning of the heart and aiding in the diagnosis, prognosis, and monitoring of cardiovascular conditions. These biomarkers, often proteins released into the bloodstream in response to heart damage or stress, serve as crucial indicators for healthcare professionals. Troponins, creatine kinase-MB (CK-MB), and B-type natriuretic peptide (BNP) are among the well-known cardiac biomarkers. The detection and analysis of these biomarkers have significantly enhanced our ability to assess cardiac health, allowing for early intervention and personalized treatment strategies. As the field of cardiac biomarkers continues to evolve, ongoing research explores novel markers and advanced diagnostic technologies, promising further advancements in cardiovascular care. The comprehensive understanding of cardiac biomarkers contributes to more accurate diagnoses, improved patient outcomes, and a deeper comprehension of heart-related diseases.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain